Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Italiano
P-161 * a Phase I-Trial Assessing Several Schedules of Oral S-1 Combined With Fixed Doses of Oxaliplatin and Irinotecan in Patients With Advanced or Metastatic Digestive Adenocarcinoma as First- Or Second-Line Treatment
Annals of Oncology
Medicine
Oncology
Hematology
Related publications
Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-Line Treatment for Patients With Recurrent or Metastatic Biliary Tract Cancer
Cancer Research and Treatment
Cancer Research
Oncology
Randomized Phase II Trial of First-Line Treatment With Tailored Irinotecan and S-1 Therapy Versus S-1 Monotherapy for Advanced or Recurrent Gastric Carcinoma (JFMC31-0301)
Anti-Cancer Drugs
Cancer Research
Oncology
Pharmacology
Phase II Trial of Vatalanib in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma After First-Line Gemcitabine Therapy (PCRT O4-001)
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Phase I Trial of Oxaliplatin Plus S-1 Chemotherapy in Patients With Metastatic Colorectal Cancer
Oncology Letters
Cancer Research
Oncology
Phase I/Ii Randomized Trial of Sorafenib and Bevacizumab as First-Line Therapy in Patients With Locally Advanced or Metastatic Hepatocellular Carcinoma: North Central Cancer Treatment Group Trial N0745 (Alliance)
Targeted Oncology
Cancer Research
Oncology
Pharmacology
Capecitabine and Oxaliplatin in Combination as First- Or Second-Line Therapy for Metastatic Breast Cancer: A Wisconsin Oncology Network Trial
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Oxaliplatin Plus Irinotecan Compared With Irinotecan Alone as Second-Line Treatment After Single-Agent Fluoropyrimidine Therapy for Metastatic Colorectal Carcinoma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Combination Therapy With Docetaxel and S-1 as a First-Line Treatment in Patients With Advanced or Recurrent Gastric Cancer: A Retrospective Analysis
World Journal of Surgical Oncology
Surgery
Oncology
Phase I/Ii Study of S-1 Combined With Paclitaxel in Patients With Unresectable and/or Recurrent Advanced Gastric Cancer
British Journal of Cancer
Cancer Research
Oncology
